Atrial Fibrillation and Sudden Death: Are they linked? Mariell Jessup MD Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania.

Slides:



Advertisements
Similar presentations
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 ICD data.
Advertisements

© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
Natale MARRAZZO Francesco SOLIMENE Quando la CRT-P può bastare?
Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure Presented at American College of Cardiology Scientific Sessions.
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
Outcome of Patients with Advanced Heart Failure who Receive Device- Based Therapy for Primary Prevention of Sudden Cardiac Death, G. Amit, N. Samniah,
Thursday 4/12/2014 Hassan Alahmadi Medical Resident ( R1)
“Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure (GWTG-HF)” Daniel E. Forman, MD; Christopher.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
1 Key points – Heart Failure within Bradford 2011.
1 Clinical Overview of Atrial Fibrillation Edward L.C. Pritchett, M.D. Consulting Professor of Medicine Divisions of Cardiology and Clinical Pharmacology.
Ablation for Paroxysmal Atrial Fibrillation (APAF) Trial Presented at The American College of Cardiology Scientific Session 2006 Presented by Dr. Carlo.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Prognostic Value of Programmed Electrical Stimulation Among Implantable Cardioverter-Defibrillator Recipients Real-World Data from the Israeli National.
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
The Current Indications for ICD in HF Patients Should be Driven by HF Guidelines Mariell Jessup MD Professor of Medicine University of Pennsylvania Philadelphia,
Arrhytmia In Heart Failure
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Muhammad S Ajmal MBBS Aravind Herle MD FACC. Atrial fibrillation (AF) A supraventricular tachyarrhythmia characterized by uncoordinated atrial activation.
Renal function and clinical outcomes of patients undergoing ICD and CRTD implantation- Data from the Israeli ICD Registry Alon Eisen, Mahmoud Souleiman,
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
First author: Sendrea Octavian-Laurentiu Coordinator: Senior Lecturer Gozar Liliana, MD, PhD.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
M. JESSUP Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
EP Show – Aug 2003 ICDs – Secondary prevention The EP Show: Which ICD for which patient? Part 1: Secondary prevention Eric Prystowsky MD Director, Clinical.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
Does the Choice of Antihypertensive Agent Affect Risk for AFib? Summary and Comment by Joel M. Gore, MD Published in Journal Watch Cardiology February.
ARISTOTLE Objectives Primary: test for noninferiority of apixaban, a novel oral direct factor Xa inhibitor, versus warfarin Secondary: test for superiority.
IRIS Post-hoc Analysis Background IRIS compared the safety and efficacy of early ICD implantation with medical treatment alone in 898 patients at high.
Continuous Positive Airway Pressure for Heart Patients with Central Sleep Apnea Presented at American College of Cardiology Scientific Sessions 2005 Presented.
IMPLANTABLE DEFIBRILLATOR By: Victor J. Gabbidon.
Impact of ISDN-hydralazine on mortality and morbidity of African-American patients with Heart Failure A-Heft Trial Presented at American Heart Association.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
EP show – June 2004 EP show The EP show: Risk stratification for sudden death Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent.
EP Show – Dec 2003 ICDs – Primary prevention The EP Show: Guidelines and reimbursement at the crossroads: Primary prevention with ICDs Eric Prystowsky.
A-4 Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Pierre Jais Atrial Fibrillation Ablation vs. Antiarrhythmic Drugs Trial.
Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.
European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spectrum and prognostic significance of arrhythmias.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Inappropriate Implantable Cardioverter-Defibrillator.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Beta-Blockers and Outcome in Heart Failure and Atrial.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Influence of Left Ventricular Ejection Fraction.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Predictors of Implantable Cardioverter-Defibrillator.
Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation Jens Cosedis Nielsen, M.D., D.M.Sc., Arne Johannessen, M.D., D.M.Sc., Pekka.
Journal of the American College of Cardiology Vol. 61, No. 4, 2013 Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation.
Atrial Fibrillation: When Should You Consider Ablation?
Reactive ATP and MINERVA
Figure 1 Incidence and total numbers of SCD in patients with depressed LV systolic function and in patients with preserved LV function. The incidence of.
Arrhythmogenic right ventricular dysplasia
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Dirty Laundry.
Catheter Ablation for the Cure of Atrial Fibrillation Study
Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD  Heart Rhythm 
Colorectal cancer and atrial fibrillation: a case-control study
Mahesh Anantha Narayanan et al. JACEP 2017;3:
Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Gianluigi Savarese et al. JCHF 2016;4:
Presentation transcript:

Atrial Fibrillation and Sudden Death: Are they linked? Mariell Jessup MD Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Cardiology Clinics 2009; 27:151 AF doubles in incidence with each decade of age, afflicting up to 10% of patients older than the age of 80 years. Subanalyses of major primary and secondary prevention ICD trials have all shown preserved efficacy of ICDs in the elderly. Heart failure (HF) is one of the most significant factors for patients at risk for SCD and AF. AF can be found in up to 40% of patients who have symptomatic HF.

AF affects more than 2 million Americans and 6 million in Europe. AF in the ICD population leads to special problems, such as the delivery of inappropriate ICD therapies. Offers special opportunities for assessing therapy effectiveness by direct interrogation of AF burden. Many of the factors that predispose people to AF are the same risk factors that put them at risk for SCD.

Among patients with HF in general, AF has not been consistently shown to increase mortality. Specific data on the additional risk for AF in patients with ICDs are limited and conflicting. Inappropriate shocks comprise 12% to 30% of all shock therapies delivered. Supraventricular tachyarrhythmia is the most common independent predictor of inappropriate shocks, and of these, AF is the most frequent type (44%–51%).

AF is sometimes considered as a trigger for ventricular arrhythmia. Multiple reports have consistently identified an association between AF and appropriate ICD therapy.

Atrial Fibrillation and Sudden Death: Are they linked? The same risk factors that lead to AF cause SCD. AF may confer a higher independent mortality. The presence of AF in ICD patients is ominous. Treatment of AF may prompt sudden death. –Especially with anti-arrhythmics or ablation. Sleep apnea is a special link of AF and SCD Genetic abnormalities and special sub-groups will become increasingly important in the future.